Correlation of regional proton magnetic resonance spectroscopic metabolic changes with cognitive deficits in mild Alzheimer disease

Archives of Neurology

Volumn 59, Issue 6, 2002, Pages 955-962

  Chantal, Sophie ^a,b   Labelle, Martin ^c   Bouchard, Rémi W ^a   Braun, Claude M J ^b   Boulanger, Yvan ^c  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^c UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; CREATINE PHOSPHATE; INOSITOL; N ACETYLASPARTIC ACID; WATER;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN FUNCTION; BRAIN METABOLISM; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; EQUIPMENT; FEMALE; FRONTAL CORTEX; HEMISPHERIC DOMINANCE; HUMAN; LANGUAGE; MALE; METABOLITE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; PSYCHOMETRY; TEMPORAL CORTEX; TEMPORAL LOBE; VERBAL MEMORY; VISION;

EID: 0036283020     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.59.6.955     Document Type: Article

References (43)

1. Dementia: A review emphasizing clinicopathologic correlation and brain-behavior relationships
2. Evolution of the neuropathology of Alzheimer's disease
3. The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease
4. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease
5. Memory and MRI-based hippocampal volumes in aging and AD
6. Cognitive deficits and local metabolic changes in dementia of the Alzheimer type
7. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease
8. Heterogeneous anterior-posterior metabolic patterns in dementia of the Alzheimer type
9. Relations between neuropsychological and cerebral metabolic asymmetries in early Alzheimer's disease
10. 1H MRS study
11. Proton magnetic resonance spectroscopy can differentiate Alzheimer's disease from normal aging
12. Correlations between cognitive status and cerebral inositol in Alzheimer's type dementia
13. Alzheimer disease: Absolute quantification of cerebral metabolites in vivo using localized proton magnetic resonance spectroscopy
14. 99mTc-HMPAO-SPECT in normal aging, age-associated memory impairment, and probable Alzheimer's disease from normal aging
15. Probable Alzheimer disease: Diagnosis with proton MR spectroscopy
16. Proton magnetic resonance spectroscopy in dementia of Alzheimer type
17. 1H MRS study of probable Alzheimer's disease and normal aging: Implications for longitudinal monitoring of dementia progression
18. Alzheimer disease and subcortical ischemic vascular dementia: Evaluation by combining MR imaging segmentation and H-1 MR spectroscopic imaging
19. Alzheimer disease: Quantitative H-1 MR spectroscopic imaging of frontoparietal brain
20. Proton MR spectroscopy detects a relative decrease of N-acetylaspartate in the medial temporal lobe of patients with AD
21. Cortical and subcortical chemical pathology in Alzheimer's disease as assessed by multislice proton magnetic resonance spectroscopic imaging
22. In vivo brain concentrations of N-acetyl compounds, creatine and choline in Alzheimer disease
23. 1H MRS relate to recognition memory
24. Lateralization of brain function in childhood revealed by magnetic resonance spectroscopy
25. Dual voxel proton magnetic resonance spectroscopy in the healthy elderly: Subcortical-frontal axonal N-acetylaspartate levels are correlated with fluid cognitive abilities independent of structural brain changes
26. Metabolic and cognitive response to human traumatic brain injury: A quantitative proton magnetic resonance study
27. "Mini-Mental state": A practical method for grading the cognitive state of patients for the clinician
28. A new rating scale for Alzheimer's disease
29. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Forces on Alzheimer's Disease
30. The Clinical Dementia Rating (CDR): Current version and scoring rules
31. Cerebral blood flow in dementia
32. Pathological verification of ischemic score in differentiation of dementias
33. Hippocampal sclerosis and human memory
34. 2 relaxometry
35. Role of increased cerebral myo-inositol in the dementia of Down syndrome
36. Staging of Alzheimer's disease-related neurofibrillary changes
37. In vivo MR spectroscopy of human dementia
38. Memory and the hippocampus: A synthesis from findings with rats, monkeys, and humans
39. Hippocampal pathology reflects memory deficit and brain imaging measurements in Alzheimer's disease: Clinicopathologic correlations using three sets of pathologic diagnostic criteria